Literature DB >> 18162005

Management of chronic daily headache in children and adolescents.

Kenneth J Mack1, Jack Gladstein.   

Abstract

Chronic daily headache (CDH) occurs in 1-2% of children and adolescents. It can evolve from either episodic tension-type headache or episodic migraine, or can appear with no previous headache history. As with other primary headache disorders, treatment is based on the level of disability. There are children and adolescents who cope well, but there are others who are markedly disabled by their chronic headaches. As in adults, children and adolescents with CDH are at risk for medication overuse. CDH is a diagnosis of exclusion, based on a thorough history, normal physical examination, and negative neuroimaging findings. Along with the chronic headaches, children with this condition may have co-morbid sleep problems, autonomic dysfunction, anxiety, and/or depression. Principles of treatment include identifying migrainous components, stopping medication overuse, stressing normalcy, using rational pharmacotherapy, and addressing co-morbid conditions. Successful outcomes often involve identifying an appropriate headache preventative, reintegration into school, and family participation in resetting realistic expectations.

Entities:  

Mesh:

Year:  2008        PMID: 18162005     DOI: 10.2165/00148581-200810010-00003

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  37 in total

1.  Chronic daily headache in adolescents: prevalence, impact, and medication overuse.

Authors:  Shuu-Jiun Wang; Jong-Ling Fuh; Shiang-Ru Lu; Kai-Dih Juang
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 2.  Drug overuse and rebound headache.

Authors:  Stephen D Silberstein; Dongmei Liu
Journal:  Curr Pain Headache Rep       Date:  2002-06

3.  Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.

Authors:  A V Krymchantowski; J S Barbosa
Journal:  Arq Neuropsiquiatr       Date:  2001-09       Impact factor: 1.420

4.  Cyproheptadine produced modest increases in total caloric intake by humans.

Authors:  S D Comer; M Haney; M W Fischman; R W Foltin
Journal:  Physiol Behav       Date:  1997-10

5.  Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

Authors:  L C Adelman; J U Adelman; R Von Seggern; L K Mannix
Journal:  Headache       Date:  2000 Jul-Aug       Impact factor: 5.887

6.  Effectiveness of amitriptyline in the prophylactic management of childhood headaches.

Authors:  A D Hershey; S W Powers; A L Bentti; T J Degrauw
Journal:  Headache       Date:  2000 Jul-Aug       Impact factor: 5.887

Review 7.  Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Authors:  D Lewis; S Ashwal; A Hershey; D Hirtz; M Yonker; S Silberstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

8.  Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

Authors:  N H Raskin
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

9.  Epidemiology of chronic daily headache.

Authors:  I Kavuk; A Yavuz; U Cetindere; M W Agelink; H C Diener
Journal:  Eur J Med Res       Date:  2003-06-30       Impact factor: 2.175

10.  Diagnoses and symptom patterns in children presenting to a pediatric headache clinic.

Authors:  J Gladstein; E W Holden; L Peralta; M Raven
Journal:  Headache       Date:  1993-10       Impact factor: 5.887

View more
  2 in total

Review 1.  Chronic daily headache in children and adolescents.

Authors:  Shashi S Seshia
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Patterns of complementary and alternative medicine use in children with common neurological conditions.

Authors:  Lauren Treat; Juliette Liesinger; Jeanette Y Ziegenfuss; Katherine Humeniuk; Kavita Prasad; Jon C Tilburt
Journal:  Glob Adv Health Med       Date:  2014-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.